Abortion pill manufacturer sues FDA to preserve access and protect drug.
TL;DR Summary
GenBioPro, the manufacturer of generic mifepristone, has sued the FDA to prevent the drug from being removed from the market. The lawsuit comes on the day that the Supreme Court is expected to rule on whether restrictions should be imposed on the drug, including potentially revoking the generic version's FDA authorization. The company is seeking an order that would require the FDA to keep GenBioPro's mifepristone on the market.
- Abortion pill manufacturer sues FDA to keep drug on the market Axios
- Generic abortion pill maker GenBioPro sues FDA over its response to orders halting drug's approval CNN
- Abortion Pill Maker Sues F.D.A. to Protect Drug if a Court Orders It Off the Market The New York Times
- Abortion pill maker sues FDA to preserve access POLITICO
- Generic abortion pill maker sues FDA to maintain access The Hill
Reading Insights
Total Reads
0
Unique Readers
13
Time Saved
2 min
vs 2 min read
Condensed
82%
386 → 69 words
Want the full story? Read the original article
Read on Axios